Company Filing History:
Years Active: 2021
Title: Birgit Piater: Innovator in Bioconjugation Technology
Introduction
Birgit Piater is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of bioconjugation, particularly through her innovative work at Merck Patent GmbH. Her research focuses on developing novel peptide sequences that enhance the efficiency of bioconjugation processes.
Latest Patents
Birgit Piater holds a patent for her invention titled "Transglutamine tag for efficient site-specific bioconjugation." This invention provides novel peptide sequences for use in microbial transglutaminase-mediated bioconjugations, specifically for the manufacture of antibody-drug conjugates. The patent also discloses bioconjugation methods employing mTG2 and the novel peptide sequence motifs, along with proteins comprising these sequences and polynucleotides encoding them.
Career Highlights
Throughout her career, Birgit has demonstrated a strong commitment to advancing bioconjugation technology. Her work has not only contributed to scientific knowledge but has also paved the way for practical applications in the pharmaceutical industry.
Collaborations
Birgit has collaborated with notable colleagues, including Ulrich Betz and Harald Kolmar, to further enhance the impact of her research. These collaborations have fostered a productive environment for innovation and development in their field.
Conclusion
Birgit Piater is a trailblazer in the realm of bioconjugation, with her innovative patent and collaborative efforts significantly advancing the field. Her contributions continue to influence the development of new therapeutic strategies.